These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30685913)

  • 21. Reversible Posterior Leukoencephalopathy Syndrome (RPLS) in a Psoriasis Patient Treated With Ustekinumab.
    Dickson L; Menter A
    J Drugs Dermatol; 2017 Feb; 16(2):177-179. PubMed ID: 28300862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ustekinumab for the treatment of psoriasis: an evidence update.
    Yiu ZZ; Warren RB
    Semin Cutan Med Surg; 2018 Sep; 37(3):143-147. PubMed ID: 30215630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation Between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis Treated with Ustekinumab.
    Hesselvig JH; Egeberg A; Loft ND; Zachariae C; Kofoed K; Skov L
    Acta Derm Venereol; 2018 Mar; 98(3):335-339. PubMed ID: 29110019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ustekinumab-induced eosinophilic pneumonia during the course of ustekinumab therapy for plaque psoriasis].
    Amy de la Bretèque M; Appere-De Vecchi C; Zeboulon C; Zaien I; Sigal ML; Mahé E
    Ann Dermatol Venereol; 2015 Mar; 142(3):193-6. PubMed ID: 25624139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular toxoplasmosis in a patient treated with ustekinumab for psoriasis.
    Javadzadeh S; Gkini MA; Panos GD; Adewoyin T; Bewley A
    Clin Exp Dermatol; 2020 Aug; 45(6):802-804. PubMed ID: 32212270
    [No Abstract]   [Full Text] [Related]  

  • 26. Wells' syndrome following thiomersal-containing vaccinations.
    Koh KJ; Warren L; Moore L; James C; Thompson GN
    Australas J Dermatol; 2003 Aug; 44(3):199-202. PubMed ID: 12869046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Case Series of Patients With Psoriasis Exposed to Biologic Therapy During Pregnancy: The BIOBADADERM Register and a Review of the Literature.
    Echeverría-García B; Nuño-González A; Dauden E; Vanaclocha F; Torrado R; Belinchón I; Pérez-Zafrilla B;
    Actas Dermosifiliogr; 2017 Mar; 108(2):168-170. PubMed ID: 27765165
    [No Abstract]   [Full Text] [Related]  

  • 28. Morphea-like lesions after treatment with ustekinumab.
    Shaffer BR; Zaino M; Bowers NL; Hunter D; Feldman SR
    Dermatol Online J; 2024 Jun; 30(3):. PubMed ID: 39090052
    [No Abstract]   [Full Text] [Related]  

  • 29. Ustekinumab treatment in patients with psoriasis undergoing hemodialysis.
    Umezawa Y; Hayashi M; Kikuchi S; Fukuchi O; Yanaba K; Ito T; Asahina A; Saeki H; Nakagawa H
    J Dermatol; 2015 Jul; 42(7):731-4. PubMed ID: 25959602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study.
    Blauvelt A; Reich K; Tsai TF; Tyring S; Vanaclocha F; Kingo K; Ziv M; Pinter A; Vender R; Hugot S; You R; Milutinovic M; Thaçi D
    J Am Acad Dermatol; 2017 Jan; 76(1):60-69.e9. PubMed ID: 27663079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flare of palmoplantar psoriasis with ustekinumab.
    Daniel BS; Baker C; Foley P
    Australas J Dermatol; 2020 Feb; 61(1):63-65. PubMed ID: 31372980
    [No Abstract]   [Full Text] [Related]  

  • 32. Cutaneous protothecosis in a patient on ustekinumab for psoriasis.
    Jenkinson H; Thelin L; McAndrew R; Jones KM; Talbott LB; Diven D
    Int J Dermatol; 2018 Oct; 57(10):1246-1248. PubMed ID: 29603193
    [No Abstract]   [Full Text] [Related]  

  • 33. Morphea in patients with psoriasis treated with ustekinumab: a scoping review.
    Metko D; Mehta S; Vender R
    Arch Dermatol Res; 2024 Jul; 316(8):492. PubMed ID: 39066922
    [No Abstract]   [Full Text] [Related]  

  • 34. [Eosinophilic cellulitis: About a new pediatric case].
    Makni S; Kallel R; Chaabène H; Bahloul E; Bahri I; Turki H; Gouiaa N; Boudawara T
    Ann Pathol; 2015 Dec; 35(6):486-8. PubMed ID: 26586016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case of Wells' syndrome: A rare association with the clinical course of chronic lymphocytic leukemia.
    Omigawa C; Namiki T; Ueno M; Ugajin T; Miura K; Yokozeki H
    J Dermatol; 2019 Feb; 46(2):e57-e59. PubMed ID: 30063068
    [No Abstract]   [Full Text] [Related]  

  • 36. Liver Injury in Psoriasis Patients Receiving Ustekinumab: A Retrospective Study of 44 Patients Treated in the Clinical Practice Setting.
    Llamas-Velasco M; Concha-Garzón MJ; García-Diez A; Daudén E
    Actas Dermosifiliogr; 2015; 106(6):470-6. PubMed ID: 25912374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interstitial pneumonia in two patients with psoriasis during ustekinumab treatment.
    Kikuchi S; Umezawa Y; Hayashi M; Yanaba K; Fukuchi O; Ito T; Asahina A; Saeki H; Nakagawa H
    J Dermatol; 2016 Jun; 43(6):712-3. PubMed ID: 26703791
    [No Abstract]   [Full Text] [Related]  

  • 38. [Wells' cellulitis and bacterial necrotizing cellulitis induced by anakinra].
    Livory M; Wechsler J; Revuz J; Bagot M; Chevalier X; Poszepczynska-Guigné E
    Ann Dermatol Venereol; 2008 Dec; 135(12):839-42. PubMed ID: 19084694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety Surveillance for Ustekinumab and Other Psoriasis Treatments From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
    Papp K; Gottlieb AB; Naldi L; Pariser D; Ho V; Goyal K; Fakharzadeh S; Chevrier M; Calabro S; Langholff W; Krueger G
    J Drugs Dermatol; 2015 Jul; 14(7):706-14. PubMed ID: 26151787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stroke under treatment with ustekinumab for psoriatic arthritis.
    Aboudiab M; Andréjak M; Husein T; Goëb V
    Rev Neurol (Paris); 2019 Apr; 175(4):271-272. PubMed ID: 30638925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.